Adoptive immunotherapy with autologous T-cell infusions reduces opioid requirements in advanced cancer patients
In conclusion, ACT was capable of reducing cancer pain severity and opioid consumption and favorably modulating peripheral blood T-cell populations.
Source: Pain - Category: Anesthesiology Tags: Research Paper Source Type: research
More News: Anesthesiology | Cancer | Cancer & Oncology | Immunotherapy | Morphine | Oral Cancer | Pain